|  |  | 

India Top Headlines

Efforts are intensifying for mass production of vaccines, making them available quickly: Government | India News

NEW DELHI: Efforts are intensifying to mass-produce vaccines and make them available in the shortest time possible, a senior government official said Wednesday, emphasizing that India currently has a promising pipeline of four to five Covid vaccine candidates. -19, while three have already been approved for emergency use.
Biotechnology Department Secretary Renu Swarup said financial support of Rs 400 million is being provided to the candidate vaccines Zydus Cadilla, Biological E, Gennova and Bharat Biotech (single dose intranasal vaccine).
His statement came days after the government expanded the vaccination campaign to cover everyone over the age of 18.
“There are three vaccines in India that have been approved for emergency use authorization: Covishield by the Serum Institute of India (SII), Covaxin by Bharat Biotech International Ltd. (BBIL) and the Russian vaccine, Sputnik-V. In addition of these, there is a promising portfolio of 4-5 candidates in advanced clinical stages of development, “Swarup told PTI.
Zydus Cadila’s DNA vaccine candidate, BioE’s protein subunit vaccine candidate, Gennova’s mRNA vaccine candidate and Bharat Biotech’s single-dose intranasal vaccine candidate are in advanced stages of clinical trials, he said. .
“The Department of Biotechnology has provided technical, advisory and financial support for these vaccine candidates during their initial development. Now, under the Covid Suraksha mission, financial support of nearly Rs 400 million is being provided for the late-stage clinical development of these vaccine candidates.
“Manufacturers already have existing capacities and can contribute around 15-20 million doses per month, which may be available for immunization, once approved,” Swarup said.
Six Indian companies, including Dr. Reddy’s, will collectively produce 70 crore doses per year of the Russian Sputnik V vaccine, he added.

Original source